i
U.S. Public Health Service guideline on infectious disease issues in xenotransplantation
-
August 24, 2001
Details:
-
Corporate Authors:Center for Biologics Evaluation and Research (U.S.) ; Centers for Diseases Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.) ; United States, Department of Health, Education, and Welfare., Office of the Assistant Secretary for Planning and Evaluation ; United States, Health Resources and Services Administration.
-
Description:Several developments have fueled the renewed interest in xenotransplantation--the use of live animal cells, tissues and organs in the treatment or mitigation of human disease. The world-wide, critical shortage of human organs available for transplantation and advances in genetic engineering and in the immunology and biology of organ/tissue rejection have renewed scientists' interest in investigating xenotransplantation as a potentially promising means to treat a wide range of human disorders. This situation is highlighted by the fact that in the United States alone, 13 patients die each day waiting to receive a life-saving transplant to replace a diseased vital organ.
Includes bibliographical references (p. 36-48).
-
Content Notes:This report is being reprinted with the permission of the Center for Biologics Evaluation and Research, Food and Drug Administration; the Health Resources and Services Administration; the National Institutes of Health; the National Center for Infectious Diseases, Centers for Disease Control and Prevention; and the Assistant Secretary for Planning and Evaluation, Office of the Secretary, Department of Health and Human Services. It is reprinted as a courtesy to the MMWR readership.
-
Subjects:
-
Series:
-
Pubmed ID:11534745
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: